Simvastatin therapy in climacteric women with atherogenic dyslipoproteinemias
The study aimed to assess real-world clinical practice effectiveness and safety of simvastatin therapy in climacteric women. A prospective cohort study included 82post-menopausal women with lipid-lowering therapy indications; median age 56,5 (52,0-60,0) years. Simvastatin therapy lasted for one year...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2008-04-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1540 |